MSI Financial Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$401K Sell
10,329
-1,550
-13% -$62.6K 0.01% 787
2016
Q3
$498K Sell
11,879
-5,165
-30% -$212K 0.02% 675
2016
Q2
$630K Sell
17,044
-11,987
-41% -$470K 0.02% 555
2016
Q1
$1.11M Sell
29,031
-2,365
-8% -$91.9K 0.05% 347
2015
Q4
$1.59M Buy
31,396
+3,737
+14% +$185K 0.07% 264
2015
Q3
$1.26M Buy
27,659
+682
+3% +$38.1K 0.1% 215
2015
Q2
$1.57M Buy
26,977
+2,108
+8% +$121K 0.11% 204
2015
Q1
$1.37M Buy
24,869
+15,875
+177% +$858K 0.1% 233
2014
Q4
$452K Buy
8,994
+3,909
+77% +$191K 0.05% 382
2014
Q3
$235K Buy
5,085
+2,665
+110% +$120K 0.03% 536
2014
Q2
$106K Buy
2,420
+1,750
+261% +$70.9K 0.01% 782
2014
Q1
$28K Buy
670
+480
+253% +$20.5K ﹤0.01% 1292
2013
Q4
$7K Buy
190
+30
+19% +$1.08K ﹤0.01% 1844
2013
Q3
$6K Sell
160
-100
-38% -$3.31K ﹤0.01% 1637
2013
Q2
$8K Buy
+260
New +$7.39K ﹤0.01% 1645

Other funds holding PBE

MSI Financial Services's PBE Position: Q4 2016 in Review

MSI Financial Services reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 13% in Q4 2016, selling an estimated $62.6K and leaving 10,329 shares worth $401K. The position accounts for 0.01% of the portfolio, ranked #787.

MSI Financial Services first reported a position in PBE in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.59M in Q4 2015. 68 funds tracked by Wall St. Rank hold PBE as of Q4 2016.

  • MSI Financial Services held 10,329 shares of Invesco Biotechnology & Genome ETF worth $401K as of Q4 2016.
  • MSI Financial Services sold 1,550 Invesco Biotechnology & Genome ETF shares in Q4 2016, an estimated $62.6K.
  • Invesco Biotechnology & Genome ETF made up 0.01% of MSI Financial Services's portfolio in Q4 2016, its #787 holding.
  • MSI Financial Services first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 15 quarters since.
  • MSI Financial Services's Invesco Biotechnology & Genome ETF position peaked at $1.59M in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.